Chinook Therapeutics, Inc.

Connor, Clark & Lunn Investment Management Ltd.

Report date

3/31/2023

Quarter

2023 Q1

Filed

5/10/2023

Shares

170,211

Value ($000)

3,940

Weight

0.0%

2021 Q4 - 2023 Q1 (6 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q1	5/10/2023	3,940	0.0%	170,211	3/31/2023
2022 Q4	2/10/2023	6,178	0.0%	235,816	12/31/2022
2022 Q3	11/10/2022	5,648	0.0%	287,284	9/30/2022
2022 Q2	8/5/2022	2,115	0.0%	120,942	6/30/2022
2022 Q1	5/12/2022	428	0.0%	26,147	3/31/2022
2021 Q4	2/10/2022	331	0.0%	20,266	12/31/2021